It has been reported that the LIN28A and LIN28B genes are reactivated in many human malignancies, such as breast cancer, colon cancer, lung cancer, ovarian cancer and hepatocellular carcinoma (HCC), and their expression is correlated with poor clinical disease outcomes [12]. The gene discussed is LIN28B; the disease is breast cancer.